resveratrol has been researched along with Metaplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, W; Li, J; Ma, J; Ma, Q; Qian, W; Qin, T; Wang, L; Xiao, Q; Xiao, Y; Yue, Y; Zhou, C | 1 |
| Feng, C; Jia, Q; Jiang, S; Lu, W; Ni, Z; Ning, H; Shi, Y; Tong, M; Wang, J; Yao, T; Zhang, J; Zhao, J | 1 |
| Li, Y; Liu, QH; Martin, RC; Wo, J; Woodall, CE | 1 |
3 other study(ies) available for resveratrol and Metaplasia
| Article | Year |
|---|---|
Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation.
Topics: Animals; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cells, Cultured; Ceruletide; Homeodomain Proteins; Metaplasia; Mice; Mice, Transgenic; NF-kappa B; Pancreatitis; Proto-Oncogene Proteins p21(ras); Resveratrol; Signal Transduction; Trans-Activators | 2020 |
Resveratrol inhibits bile acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4 signalling pathway.
Topics: Bile Acids and Salts; Cell Cycle Proteins; Forkhead Transcription Factors; Humans; Metaplasia; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stomach Neoplasms; Transfection | 2021 |
Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catalase; Disease Models, Animal; Disease Progression; Esophageal Neoplasms; Esophagus; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Male; Metaplasia; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2009 |